Treatment of Recurrent Hepatitis C After Liver Transplantation

NCT00151580 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation
Hepatitis C

Interventions

DRUG: Ribavirin
DRUG: Placebo

Sponsor

Rennes University Hospital

Collaborators

[object Object]
[object Object]